Last Updated:
Name Designation Appointment Date Status
Vijayakumar Krishnan

Appointed as Director since December 2011

Director 02-Dec-2011 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Wyenne Davis Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Thiruvil Ramchandran

Appointed as Managing Director since December 2011

Managing Director 02-Dec-2011 Current
Areeckal Midhun

Appointed as Director since July 2017

Director 08-Jul-2017 Current
Ratheesh Chakyatt

Appointed as Director since July 2017

Director 08-Jul-2017 Current

People Timeline

Explore the timeline of key personnel in Wyenne Davis Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address N0. 12/355, Hebbar Compound Chandranagar, Palakkad Kerala, 678007, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Wyenne Davis Pharmaceuticals Private Limited through their registered address at N0. 12/355, Hebbar Compound Chandranagar, Palakkad Kerala, 678007, India, or via their website at wyennedavis.com. Social media links are also provided where applicable.
The current directors of Wyenne Davis Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • VIJAYAKUMAR KRISHNAN
  • THIRUVIL RAMCHANDRAN
  • AREECKAL MIDHUN
  • RATHEESH CHAKYATT
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available